CAMP Stock Price | CAMP4 THERAPEUTICS CORPORATION P/E, Revenue, EPS, & Forecasts

CAMP4 THERAPEUTICS CORPORATION • CAMP

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About CAMP4 THERAPEUTICS CORPORATION

Ticker

CAMP

Trading on

NASDAQ

ISIN

US13463J1016

Industry

Biotechnology

Sector

Healthcare

CEO

Joshua Mandel-Brehm

Headquarters

One Kendall Square, Cambridge, MA, United States, 02139

Employees

Website

camp4tx.com

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001 for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP to treat synaptic Ras GTPase activating protein 1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Metrics

BasicAdvanced

Market cap

$103M

P/E ratio

EPS

-$2.64

Dividend Yield

0.00%

Beta

Forward P/E ratio

EBIDTA

$-50.8M

Ex dividend date

Price & volume

Market cap

$103M

Average daily volume

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

Earnings

EPS

-$2.64

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

$-50.8M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

52-week High

$12.30

52-week Low

$3.50

50-day moving average

$5.59

200-day moving average

$7.03

Short ratio

3.48

Short %

1.81%

Management effectiveness

ROE (TTM)

0.00%

ROA (TTM)

0.00%

Profit margin

0.00%

Gross profit margin

$-37.9M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

20.2M

Float

3.9M

Insiders %

35.40%

Institutions %

56.95%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 4 analysts.

Average price target

$19.91

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.02

-$0.03

33.33%

Q2 • 22Beat

$0.01

$0.04

75.00%

Q2 • 23Beat

-$0.01

$0.03

133.33%

Q3 • 23Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$53.6M

$-85M

158.52%

Q4 • 23

$0M

$-13.5M

∞%

Q3 • 24

100.00%

84.14%

∞%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$29.9M

$177M

591.30%

Q2 • 24

$21.4M

$180M

844.13%

Q3 • 24

28.65%

1.85%

42.76%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$1.8M

$-0.2M

$-0M

$-0.5M

Q4 • 23

$-9.7M

$0M

$-0.4M

$-9.7M

Q3 • 24

629.67%

100.00%

2,044.44%

1,756.90%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a CAMP4 THERAPEUTICS CORPORATION share?

CAMP4 THERAPEUTICS CORPORATION shares are currently traded for undefined per share.

How many shares does CAMP4 THERAPEUTICS CORPORATION have?

CAMP4 THERAPEUTICS CORPORATION currently has 20.2M shares.

Does CAMP4 THERAPEUTICS CORPORATION pay dividends?

No, CAMP4 THERAPEUTICS CORPORATION doesn't pay dividends.

What is CAMP4 THERAPEUTICS CORPORATION 52 week high?

CAMP4 THERAPEUTICS CORPORATION 52 week high is $12.30.

What is CAMP4 THERAPEUTICS CORPORATION 52 week low?

CAMP4 THERAPEUTICS CORPORATION 52 week low is $3.50.

What is the 200-day moving average of CAMP4 THERAPEUTICS CORPORATION?

CAMP4 THERAPEUTICS CORPORATION 200-day moving average is $7.03.

Who is CAMP4 THERAPEUTICS CORPORATION CEO?

The CEO of CAMP4 THERAPEUTICS CORPORATION is Joshua Mandel-Brehm.

How many employees CAMP4 THERAPEUTICS CORPORATION has?

CAMP4 THERAPEUTICS CORPORATION has 53 employees.

What is the market cap of CAMP4 THERAPEUTICS CORPORATION?

The market cap of CAMP4 THERAPEUTICS CORPORATION is $103M.

What is the P/E of CAMP4 THERAPEUTICS CORPORATION?

The current P/E of CAMP4 THERAPEUTICS CORPORATION is null.

What is the EPS of CAMP4 THERAPEUTICS CORPORATION?

The EPS of CAMP4 THERAPEUTICS CORPORATION is -$2.64.

What is the PEG Ratio of CAMP4 THERAPEUTICS CORPORATION?

The PEG Ratio of CAMP4 THERAPEUTICS CORPORATION is null.

What do analysts say about CAMP4 THERAPEUTICS CORPORATION?

According to the analysts CAMP4 THERAPEUTICS CORPORATION is considered a buy.